ResMed Inc (RMD)
NYSE • Healthcare
August 19, 2026 at 14:16 UTC
About ResMed Inc
ResMed Inc. (NYSE: RMD) makes and markets healthcare devices and connected digital solutions for sleep, respiratory, and out-of-hospital care. The company operates in the medical technology field and generated $5.1 billion in revenue in FY2025. Its business spans device hardware, software, and related services used across clinical and home-based care settings.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ResMed Inc's Technical Indicators Summary
RMD’s technicals are mixed yet skew toward accumulation with medium-term support intact while near-term momentum is soft. MACD is bullish and the stock trades above its 20- and 50-day averages, but it sits below the 10-day and the 200-day, indicating short-term softness inside a longer-term base. ADX remains low, so trend conviction is limited, ATR shows moderate volatility, and OBV points to underlying buying despite recent price softness. The pivot level is effectively neutral near the current price. Technical takeaway: Buy — mid-term moving averages and positive MACD support the thesis, though short-term momentum is weak.
| Indicator | Value |
|---|---|
RSI (14) | 56.16 |
Stochastic %K (14, 3, 3) | 73.84 |
CCI (20) | 57.03 |
WPR (14) | -32.28 |
Momentum (10) | -3.16 |
MFI | 66.64 |
MACD Level (12, 26) | 5.59 |
Bollinger Bands | $191.88 - $236.72 |
ATR (14) | $7.11 (3.23%) |
ADX (14) | 16.52 |
OBV | -15,133,816 |
Classic Pivot Point | $220.99 |
Fibonacci Pivot Point | $220.99 |
Simple Moving Averages | $204.80 - $229.42(5 indicators) |
Exponential Moving Averages | $210.43 - $230.63(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Sellers had a minor edge in the last trading session, as RMD slipped to 219.98, a fractional -0.18% decline. Oxbow Advisors LLC acquired a $5.57 million stake in RMD, signaling potential renewed buying interest.
Trading Volume
Below 10d avg (1.7M)
992.9K
vs S&P 500 Today
Outperforming Market
+0.51%
52-Week Position
Mid-range
35%
Updated: August 19, 2026 at 12:44 UTC
Quote Summary
RMD Headlines
RTX, P&G and ResMed in Focus After New Updates
April 20, 2026
Institutions Shift Positions in Major Blue-Chip Stocks
April 17, 2026
2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks
December 7, 2025